Cubist Systematic Strategies’s Zentalis Pharmaceuticals ZNTL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $372K | Buy |
320,318
+242,106
| +310% | +$281K | ﹤0.01% | 1098 |
|
|
2025
Q1 | $124K | Sell |
78,212
-102,012
| -57% | -$162K | ﹤0.01% | 1243 |
|
|
2024
Q4 | $546K | Buy |
+180,224
| New | +$546K | ﹤0.01% | 966 |
|
|
2022
Q4 | – | Sell |
-72,768
| Closed | -$1.58M | – | 3630 |
|
|
2022
Q3 | $1.58M | Buy |
+72,768
| New | +$1.58M | 0.01% | 1753 |
|
|
2022
Q2 | – | Sell |
-7,958
| Closed | -$367K | – | 4065 |
|
|
2022
Q1 | $367K | Buy |
+7,958
| New | +$367K | ﹤0.01% | 2696 |
|
|
2021
Q4 | – | Sell |
-6,968
| Closed | -$464K | – | 3668 |
|
|
2021
Q3 | $464K | Buy |
6,968
+6,551
| +1,571% | +$436K | 0.01% | 2083 |
|
|
2021
Q2 | $22K | Buy |
+417
| New | +$22K | ﹤0.01% | 2842 |
|
|
2021
Q1 | – | Sell |
-5,254
| Closed | -$273K | – | 2998 |
|
|
2020
Q4 | $273K | Buy |
+5,254
| New | +$273K | ﹤0.01% | 2085 |
|